If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 221 - 230 of 279
Impella-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Objective
Impella-Supported PCI in Complex Coronary Artery Disease PROTECT IV
Protocol No
CVC-ABIOMED-PROTECT-IV
Categories
A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes
Objective
A study of AG-946 in patients with anemia due to LR-MDS
Protocol No
AGIOS-AG946-C-002
Categories
A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors
Objective
The study is researching an investigational drug called REGN7075 by itself and in combination
with cemiplimab with or without chemotherapy.
with cemiplimab with or without chemotherapy.
Protocol No
REGENERON-R7075-ONC-2009
A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Objective
Study of BMX-001 radioprotector with chemoradiation therapy for H/N cancer patients
Protocol No
NRG-CC013
Categories
A Phase I Study of Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)
Objective
In this study, we want to find out whether the reduction of the radiation treatment fractions (to 10, 7, or 5 instead of 30) with a higher dose per fraction may be delivered in resected Head and Neck Squamous Cell Carcinoma patients.
Protocol No
IIT-ZENGA-HYPR-HN
Categories
Hand Function as a Biomarker of Brain Tumor Motor Cortical Involvement
Objective
Hand Function in Brain Tumors
Protocol No
IIT-KRUCOFF-HAND-FUNCTION
Categories
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS SAmples Study
Objective
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples (PANCREAS)
Protocol No
IIT-TSAI-PANCREAS-TRIAL
Categories
Single-Arm Study of Toripalimab in Combination with Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants (TRANSPARENT)
Objective
Study of toripalimab for recurrent metastatic nasopharyngeal carcinoma treatment naive patients
Protocol No
RTOG-FND-3521-CHS-007-01
Categories
A Phase 3 Randomized, Open-Label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Next-generation Hormonal Agent (NHA) and Tax
Objective
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Protocol No
MERCK-MK-5684-003
Categories
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib vs Physicians Choice in Subjects with FGFR-Altered, Chemotherapy- and FGFR Inhibitor-Cholangiocarcinoma
Objective
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma (FIRST-308)
Protocol No
TRANSTHERA-TT420C2308
Categories